James J. Dignam to Kallikreins
This is a "connection" page, showing publications James J. Dignam has written about Kallikreins.
Connection Strength
0.186
-
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. J Clin Oncol. 2020 09 10; 38(26):3032-3041.
Score: 0.186